Pseudomonas: Roxithromycin resistance


Roxithromycin description

23S rRNA of 50S ribosomal subunit, protein synthesis inhibitor

Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.

Roxithromycin resistance gene: mexd